Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Paediatric tumour boards in Spain: a national survey.
Berlanga P, Segura V, Juan Ribelles A, Sánchez de Toledo P, Acha T, Castel V, Cañete A. Berlanga P, et al. Clin Transl Oncol. 2016 Sep;18(9):931-6. doi: 10.1007/s12094-015-1466-9. Epub 2015 Dec 22. Clin Transl Oncol. 2016. PMID: 26693730
Emerging drugs for neuroblastoma.
Castel V, Segura V, Berlanga P. Castel V, et al. Among authors: berlanga p. Expert Opin Emerg Drugs. 2013 Jun;18(2):155-71. doi: 10.1517/14728214.2013.796927. Epub 2013 May 22. Expert Opin Emerg Drugs. 2013. PMID: 23692586 Review.
Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition.
Sanmartín E, Muñoz L, Piqueras M, Sirerol JA, Berlanga P, Cañete A, Castel V, Font de Mora J. Sanmartín E, et al. Among authors: berlanga p. Clin Cancer Res. 2017 Nov 15;23(22):6875-6887. doi: 10.1158/1078-0432.CCR-17-0593. Epub 2017 Aug 22. Clin Cancer Res. 2017. PMID: 28830922
Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy.
Urtasun A, Olivera GG, Sendra L, Aliño SF, Berlanga P, Gargallo P, Hervás D, Balaguer J, Juan-Ribelles A, Andrés MDM, Cañete A, Herrero MJ. Urtasun A, et al. Among authors: berlanga p. Cancers (Basel). 2023 Feb 23;15(5):1424. doi: 10.3390/cancers15051424. Cancers (Basel). 2023. PMID: 36900216 Free PMC article.
[Early clinical trials in paediatric oncology in Spain: a nationwide perspective].
Bautista F, Gallego S, Cañete A, Mora J, Díaz de Heredia C, Cruz O, Fernández JM, Rives S, Berlanga P, Hladun R, Juan Ribelles A, Madero L, Ramírez M, Fernández Delgado R, Pérez-Martínez A, Mata C, Llort A, Martín Broto J, Cela ME, Ramírez G, Sábado C, Acha T, Astigarraga I, Sastre A, Muñoz A, Guibelalde M, Moreno L; en nombre de la Sociedad Española de Oncología Pediátrica (SEHOP) y el Grupo de Nuevas Terapias en Oncología Pediátrica; Sociedad Española de Hematología y Oncología Pediátrica (SEHOP) and the New Drug Development Group in Pediatric Oncology. Bautista F, et al. Among authors: berlanga p. An Pediatr (Barc). 2017 Sep;87(3):155-163. doi: 10.1016/j.anpedi.2016.07.007. Epub 2017 Mar 6. An Pediatr (Barc). 2017. PMID: 28279690 Free article. Spanish.
[Current situation on fertility preservation in cancer patients in Spain: Level of knowledge, information, and professional involvement].
Garrido-Colino C, Lassaletta A, Vazquez MÁ, Echevarria A, Gutierrez I, Andión M, Berlanga P; en representación del Comité de Adolescentes de la SEHOP. Garrido-Colino C, et al. Among authors: berlanga p. An Pediatr (Barc). 2017 Jul;87(1):3-8. doi: 10.1016/j.anpedi.2016.04.019. Epub 2016 May 31. An Pediatr (Barc). 2017. PMID: 27255351 Free article. Spanish.
Longitudinally Extensive Myelitis Associated With Immune Checkpoint Inhibitors.
Picca A, Berzero G, Bihan K, Jachiet V, Januel E, Coustans M, Cauquil C, Perrin J, Berlanga P, Kramkimel N, Garel B, Devic P, Ducray F, Benazra M, Bompaire F, Leclercq D, Michot JM, Ammari S, Psimaras D. Picca A, et al. Among authors: berlanga p. Neurol Neuroimmunol Neuroinflamm. 2021 Feb 26;8(3):e967. doi: 10.1212/NXI.0000000000000967. Print 2021 May. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33637598 Free PMC article.
64 results